| Literature DB >> 34140612 |
Andrew S Monaghan1, Jessie M Huisinga2, Daniel S Peterson3,4.
Abstract
People with multiple sclerosis (PwMS) demonstrate gait impairments that are related to falls. However, redundancy exists when reporting gait outcomes. This study aimed to develop an MS-specific model of gait and examine differences between fallers and non-fallers. 122 people with relapsing-remitting MS and 45 controls performed 3 timed up-and-go trials wearing inertial sensors. 21 gait parameters were entered into a principal component analysis (PCA). The PCA-derived gait domains were compared between MS fallers (MS-F) and MS non-fallers (MS-NF) and correlated to cognitive, clinical, and quality-of-life outcomes. Six distinct gait domains were identified: pace, rhythm, variability, asymmetry, anterior-posterior dynamic stability, and medial-lateral dynamic stability, explaining 79.15% of gait variance. PwMS exhibited a slower pace, larger variability, and increased medial-lateral trunk motion compared to controls (p < 0.05). The pace and asymmetry domains were significantly worse (i.e., slower and asymmetrical) in MS-F than MS-NF (p < 0.001 and p = 0.03, respectively). Fear of falling, cognitive performance, and functional mobility were associated with a slower gait (p < 0.05). This study identified a six-component, MS-specific gait model, demonstrating that PwMS, particularly fallers, exhibit deficits in pace and asymmetry. Findings may help reduce redundancy when reporting gait outcomes and inform interventions targeting specific gait domains.Entities:
Mesh:
Year: 2021 PMID: 34140612 PMCID: PMC8211858 DOI: 10.1038/s41598-021-92353-2
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Figure 1A model of gait for people with MS. A principal component analysis of 21 gait parameters with varimax rotation produced 6 orthogonal domains of gait. Factor loadings were considered relevant at > 0.50 and are bolded. Factor loadings are listed in order of importance. The values in the circles represent the proportion of total variance explained by each domain. %h percent of height; % GC percent of the gait cycle; ML mediolateral, AP anterior–posterior; variability was calculated using the coefficient of variation.
Figure 2Radar plots illustrating the pattern of gait impairment between PwMS and controls (a) and between MS-fallers (MS-F) and MS non-fallers (MS-NF) (b). Data reflect mean values. The central dashed line represents control data. Deviations from zero along the axes indicate the number of standard deviations the MS groups differ from controls. MS gait outcomes were converted to z-scores based on control means and standard deviations. Gait variables are organized by the domains produced in the PCA analysis. (c) Represents composite domain scores between MS-F and MS-NF produced by averaging the standardized gait parameters in each domain.* indicates differences between fallers and non-fallers. * indicates a statistical difference) at the p < 0.05 level. SL stride length; ROM Shank range of motion shank; PSV peak swing velocity; SV stride velocity; ROM Knee range of motion knee; TNS turn the number of steps; TPV turn peak velocity; SW swing time; ST stance time; CAD cadence; GCT gait cycle time; ST Var stance time variability; SW Var swing time variability; ROM Knee Var range of motion knee variability, ROM Shank Var range of motion shank variability; STa stance time asymmetry; SWa swing time asymmetry; ROM TR Sag trunk sagittal range of motion; ROM TR Sag Var trunk sagittal range of motion variability; ROM TR Fron trunk frontal range of motion; ROM TR Fron Var trunk frontal range of motion variability.
Mean and standard deviation (SD) of gait parameters in Controls, MS (all), and MS faller and non-faller subgroups.
| Control vs. MS | MS-NF vs. MS-F | |||||
|---|---|---|---|---|---|---|
| Control | MS | p-value (Cohen's D) | MS-NF | MS-F | p-value (Cohen's D) | |
| Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | |||
| Stride length (% height) | 88.25 (3.32) | 84.25 (9.13) | 87.08 (6.24) | 79.19 (11.31) | ||
| ROM shank (°) | 83.65 (3.60) | 79.35 (8.75) | 82.03 (6.17) | 74.56 (10.68) | ||
| Peak swing velocity (°/s) | 430.55 (38.47) | 408.1 (58.73) | 426.82 (46.84) | 375.03 (63.77) | ||
| Stride velocity (% height/s) | 86.86 (7.83) | 81.23 (12.72) | 85.85 (9.95) | 73.00 (13.13) | ||
| ROM knee (°) | 58.92 (3.04) | 57.38 (4.82) | 58.53 (3.63) | 55.40 (5.97) | ||
| Turn number of steps | 3.85 (0.68) | 4.45 (0.94) | 4.23 (0.86) | 4.86 (0.97) | ||
| Turn peak velocity (°/s) | 188.37 (33.98) | 169.51 (40.05) | 178.67 (40.83) | 152.97 (33.35) | ||
| Stance time (% GC) | 61.74 (2.04) | 62.26 (2.70) | 0.24 (-0.21) | 62.31 (2.43) | 62.20 (3.20) | 0.83 (0.04) |
| Swing time (% GC) | 38.26 (2.04) | 37.74 (2.70) | 0.24 (0.21) | 37.69 (2.43) | 37.80 (3.20) | 0.83 (− 0.04) |
| Cadence (steps/min) | 118.07 (9.46) | 115.47 (11.43) | 0.13 (0.24) | 118.13 (9.02) | 110.78 (13.80) | |
| Gait cycle time (s) | 1.02 (0.08) | 1.05 (0.11) | 0.13 (-0.27) | 1.02 (0.08) | 1.10 (0.14) | |
| Stance time variability (% GC) | 0.02 (0.01) | 0.02 (0.01) | 0.63 (−0.08) | 0.02 (0.01) | 0.02 (0.01) | 0.23 (−0.23) |
| Swing time variability (% GC) | 0.04 (0.02) | 0.04 (0.01) | 0.23 (−0.21) | 0.04 (0.01) | 0.04 (0.01) | 0.21 (−0.24) |
| ROM knee variability (°) | 0.03 (0.01) | 0.04 (0.01) | 0.04 (0.01) | 0.04 (0.02) | 0.13 (−0.32) | |
| ROM shank variability (°) | 0.02 (0.01) | 0.02 (0.01) | 0.02 (0.01) | 0.03 (0.01) | 0.13 (−0.34) | |
| Stance time asymmetry (% GC) | 2.94 (2.36) | 3.61 (3.03) | 0.18 (−0.32) | 3.03 (2.44) | 4.76 (3.66) | |
| Swing time asymmetry (% GC) | 5.30 (4.30) | 6.02 (4.88) | 0.39 (−0.15) | 5.10 (4.19) | 7.83 (5.58) | |
| ROM trunk sagittal (°) | 4.36 (1.06) | 4.66 (1.43) | 0.21 (− 0.22) | 4.78 (1.53) | 4.47 (1.20) | 0.27 (0.21) |
| ROM trunk sagittal variability (°) | 0.18 (0.06) | 0.18 (0.05) | 0.50 (0.12) | 0.17 (0.04) | 0.19 (0.06) | 0.12 (0.07) |
| ROM trunk frontal variability (°) | 0.19 (0.06) | 0.19 (0.06) | 0.78 (−0.05) | 0.19 (0.06) | 0.19 (0.06) | 0.71 (0.07) |
| ROM trunk frontal (°) | 8.17 (1.83) | 8.97 (2.68) | 8.77 (2.61) | 9.46 (2.72) | 0.18 (-0.26) | |
MS multiple sclerosis, MS-NF people with MS that reported no falls in the last 6 months, MS-F people with MS that reported one or more falls in the previous 6 months, % GC percent of the gait cycle.
Variability was computed using the coefficient of variation. Bold indicates significance at the p < 0.05 level.
Associations between clinical characteristics and gait domains.
| R2 | ANOVA | Significant predictor | β (SE) | p value | |
|---|---|---|---|---|---|
| Stroop | 0.15 | 0.04 | Pace | 1.75 (0.81) | |
| Fatigue | 0.09 | 0.29 | – | – | – |
| Physical functioning | 0.39 | < 0.001 | Pace | 5.98 (3.02) | 0.05 |
| Fall efficacy scale | 0.37 | < 0.001 | Pace | − 3.64 (1.07) | |
| Berg balance scale | 0.43 | < 0.001 | Pace | 2.12 (0.58) |
Variables controlled for in multiple regressions: age, Expanded Disability Status Scale (EDSS), disease duration, pace, rhythm, variability, asymmetry, AP dynamic stability, ML dynamic stability. Only predictors significant at p < 0.05 level are shown. Coefficients were not interpreted if the ANOVA model was not significant at p < 0.05 level.
Participant characteristics. Mean and standard deviation (SD) reported unless noted otherwise.
| Measure | MS (n = 122) | CON (n = 45) | |
|---|---|---|---|
| Mean (SD) | Mean (SD) | p-value | |
| Age | 45.51 (9.05) | 43.71 (9.54) | 0.26 |
| Sex (female/male) | 96/26 | 37/8 | – |
| Height (m) | 1.67 (0.10) | 1.66 (0.11) | 0.70 |
| Weight (kg) | 79.5 (20.51) | 73.11 (16.14) | 0.06 |
| Fallers/non-fallers | 42/79 | 6/39 | – |
| EDSS (range) | 2.00 (0.0–5.5) | – | – |
| Physical functioning (SF-36) | 72.89 (24.60) | 96.11 (5.32) | |
| Energy and fatigue (SF-36) | 46.69 (22.12) | 70.44 (15.59) | |
| Berg balance scale | 53.07 (4.84) | – | – |
| Falls efficacy scale | 25.78 (8.51) | 18.13 (2.17) | |
| Stroop word test (interference score) | 20.12 (5.47) | 7.34 (3.64) |
MS multiple sclerosis, CON control, EDSS Expanded Disability Status Scale.
Fall status was determined if one or more fall was reported in the previous 6 months. Berg Balance data was collected in the MS group only. Bold indicates statistical significance at the p < 0.05 level.